Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-25 @ 9:54 PM
Study NCT ID:
NCT00070551
Status:
COMPLETED
Last Update Posted:
2013-06-04
First Post:
2003-10-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-09
Start Date Type:
None
Primary Completion Date:
2009-02
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2003-10-03
First Submit QC Date:
None
Study First Post Date:
2003-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-03
Last Update Post Date:
2013-06-04
Last Update Post Date Type:
ESTIMATED